Drugs - MedicineNews.net - Medical Updates

Search results for "Diabetes mellitus"

Glyxambi, a fixed-dose combination of Empagliflozin and Linagliptin, for the treatment of type 2 diabetes mellitus

The Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Glyxambi, intended for the ... read article

Qtern, a fixed-dose of Saxagliptin and Dapagliflozin, for adults with type 2 diabetes mellitus: positive opinion from CHMP

The Committee for Medicinal Products for Human Use ( CHMP ) of the European Medicines Agency ( EMA ) has issued a positive opinion, recommending the approval of Qtern ( Saxagliptin and Dapagliflozin ) ... read article

Efficacy of cinnamon in patients with type II diabetes mellitus

Multiple studies have evaluated the hypoglycemic effect of cinnamon in patients with diabetes mellitus type II, with conflicting results. Differences in baseline body mass index ( BMI ) of patient ... read article

Symptoms of insomnia in psoriasis are directly mediated by pruritus and pain

Psoriasis is an immune-mediated chronic inflammatory disorder which manifests as dermatologic lesions, and psoriatic arthritis in about 30% of cases. Psoriasis is associated with multiple comorbid ... read article

Myalept to treat congenital generalized or acquired generalized lipodystrophy

The FDA ( Food and Drug Administration ) has approved Myalept ( Metreleptin for injection ) as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients wit ... read article

Myalept as replacement therapy to treat the complications of leptin deficiency

The Food and Drug Administration ( FDA ) has approved Myalept ( Metreleptin for injection ) as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients wit ... read article

Second-line drug for type 2 diabetes mellitus: Linagliptin results in less hypoglycaemia, less weight gain and perhaps less cardiovascular risk

A new drug could offer significant advantages over existing treatments for type 2 diabetes mellitus patients who dont respond to Metformin. The new drug, Linagliptin ( Tradjenta, Trajenta ), results ... read article

Type 2 diabetes: Juvisync, a once-daily therapy for patients who need to lower blood sugar and cholesterol

Merck has announced today that the FDA ( Food and Drug Administration ) has approved Juvisync ( Sitagliptin and Simvastatin ), a new treatment for type 2 diabetes that combines the glucose-lowering me ... read article

Selective serotonin reuptake inhibitors increase risks for elderly

Older people taking new generation antidepressants are at more risk of dying or suffering from a range of serious health conditions including stroke, falls, fractures and epilepsy, a study involving r ... read article

Europe: Linagliptin for treatment of diabetes mellitus type 2 approved

Boehringer Ingelheim and Eli Lilly have received marketing authorization from the European Commission for Linagliptin 5 mg film-coated tablets ( Trajenta ) for the treatment of adults with type 2 diab ... read article

2011 - Diabetes mellitus type 2: FDA has approved Tradjenta

The FDA ( Food and Drug Administration ) has approved Tradjenta ( Linagliptin ) tablets, used with diet and exercise, to improve blood glucose control in adults with diabetes mellitus type 2. Patie ... read article

Latuda for the treatment of patients with schizophrenia

Sunovion Pharmaceuticals has announced that the FDA ( Food and Drug Administration ) has approved Latuda ( Lurasidone HCl ) tablets for the treatment of schizophrenia.Latuda is an oral, once-daily aty ... read article

Diabetes mellitus type 2: restrict the use of Rosiglitazone

The FDA ( Food and Drug Administration ) announced that it will significantly restrict the use of the diabetes drug Avandia ( Rosiglitazone ) to patients with type 2 diabetes who cannot control their ... read article

Two therapies slow progression of diabetic retinopathy

In high-risk adults with type 2 diabetes mellitus, two therapies may slow the progression of diabetic retinopathy. Intensive blood glucose control reduced the progression of diabetic retinopathy com ... read article

Potential increased risk of bladder carcinoma after two years exposure to Pioglitazone, an antidiabetic drug

LFDA ( Food and Drug Administration ) is reviewing data from an ongoing, ten-year epidemiological study designed to evaluate whether Actos ( Pioglitazone ), is associated with an increased risk of bl ... read article

Focus

Multiple sclerosis: FDA has approved Tecfidera

The FDA ( Food and Drug Administration ) has approved Tecfidera ( Dimethyl fumarate ) capsules to treat adults with relapsing forms of multiple sclerosis.Multiple sclerosis is a chronic, inflammatory, ... read article

Apremilast linked to significant and clinically meaningful improvements for the primary and major secondary endpoint in plaque psoriasis

Celgene has announced that statistical significance for the primary endpoint of PASI 75 at week 16 was achieved for patients receiving Apremilast 30 mg BID monotherapy in both the ESTEEM 1 and 2 phase ... read article

Kadcyla, a new treatment for late-stage breast cancer, approved by Food and Drug Administration

The U.S. Food and Drug Administration ) has approved Kadcyla ( Ado-Trastuzumab Emtansine ), a new therapy for patients with HER2-positive, late-stage ( metastatic ) breast cancer.HER2 is a protein inv ... read article

FISSION and NEUTRINO trial: Sofosbuvir has met primary endpoints for hepatitis C

Results from two Phase 3 studies, FISSION and NEUTRINO, evaluating a 12-week course of the once-daily nucleotide Sofosbuvir in combination with Ribavirin ( FISSION ) and in combination with Ribavirin ... read article

FDA has approved Eliquis to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation

The FDA ( Food and Drug Administration ) has approved the anti-clotting drug Eliquis ( Apixaban ), an oral tablet used to reduce the risk of stroke and dangerous blood clots ( systemic embolism ) in p ... read article

Chronic hepatitis C: Promacta for patients with thrombocytopenia to allow the initiation and maintenance of Interferon-based therapy

GlaxoSmithKline ( GSK ) has announced that the FDA ( Food and Drug Administration ) has approved Promacta ( Eltrombopag; in Europe: Revolade ) for the treatment of thrombocytopenia in patients with ch ... read article

Bosulif for chronic myelogenous leukemia, approved by Food and Drug Administration

The FDA ( Food and Drug Administration ) has approved Bosulif ( Bosutinib ) to treat chronic myelogenous leukemia ( CML ), a blood and bone marrow disease that usually affects older adults.An estimate ... read article

Increased risk of high-grade prostate cancer with 5-alpha reductase inhibitors

Men aged 55 and over with a normal digital rectal examination and PSA less than or equal to 3.0 ng/mL at baseline taking Finasteride 5 mg/day ( 5 times the dose of Propecia ) in the 7-year Prostate Ca ... read article